Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.4K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Nociception01:44

Nociception

28.3K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.3K
Pain01:20

Pain

2.0K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opioid utilization patterns among patients with cancer and non-cancer pain.

Journal of opioid management·2019
Same author

A Systematic Assessment and Monitoring Intervention to Improve Pain Management and Quality Reporting Among Home Hospice Patients.

Journal of pain and symptom management·2018
Same author

Hospice Underutilization in the U.S.: The Misalignment of Regulatory Policy and Clinical Reality.

Journal of pain and symptom management·2018
Same author

Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2018
Same author

Anesthesiology and Palliative Care: Past, Present, and Future.

Anesthesia and analgesia·2018
Same author

IL10 and Neuropathic Pain.

Journal of pain & palliative care pharmacotherapy·2017
Same journal

A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Epidural Regenerative Medicine Therapies in Managing Spinal Pain.

Current pain and headache reports·2026
Same journal

Artificial Intelligence in Neuropathic Pain: From Mechanisms to Neuromodulation and Regenerative Strategies.

Current pain and headache reports·2026
Same journal

Proposed Conditions for Pain Reprocessing Therapy Readiness: Beyond Phenotyping Neuroplastic Pain.

Current pain and headache reports·2026
Same journal

Treatment of Headache in Children and Adolescents with POTS.

Current pain and headache reports·2026
Same journal

Pediatric Headache in the Age of Social Media: A Topical Review.

Current pain and headache reports·2026
Same journal

Radiopharmaceuticals for the Treatment of Chronic Cancer Pain.

Current pain and headache reports·2026
See all related articles

Related Experiment Video

Updated: Apr 25, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

51.2K

Cannabinoids for neuropathic pain.

Perry G Fine1, Mark J Rosenfeld

  • 1Pain Research and Management Centers, School of Medicine, Department of Anesthesiology, University of Utah, Suite 200, 615 Arapeen Drive, Salt Lake City, UT, 84108, USA, perry.fine@hsc.utah.edu.

Current Pain and Headache Reports
|August 28, 2014
PubMed
Summary
This summary is machine-generated.

New nonpsychoactive cannabinoids offer potential relief for neuropathic pain, addressing limitations of current treatments. Research explores their history, development, and clinical trial results for managing nerve pain effectively.

More Related Videos

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

7.5K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.0K

Related Experiment Videos

Last Updated: Apr 25, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

51.2K
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

7.5K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.0K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Management

Background:

  • Neuropathic pain treatments have limited efficacy and significant side effects.
  • The endocannabinoid system plays a key role in pain regulation.
  • Exogenous cannabinoids show promise in preclinical and clinical studies for neuropathic pain.

Purpose of the Study:

  • To review the therapeutic potential of nonpsychoactive cannabinoids for neuropathic pain.
  • To explore the history, pharmacologic development, and clinical trial outcomes.
  • To discuss future directions for orally bioavailable cannabinoid therapies.

Main Methods:

  • Literature review of historical data.
  • Analysis of pharmacologic development pathways.
  • Examination of clinical trial results for neuropathic pain management.
  • Assessment of orally bioavailable, nonpsychoactive cannabinoid formulations.

Main Results:

  • Evidence suggests exogenous cannabinoids are effective in experimental neuropathic pain models.
  • Growing evidence supports therapeutic use in human neuropathic pain conditions.
  • Nonsmoked, orally bioavailable, nonpsychoactive cannabinoids present a promising treatment avenue.

Conclusions:

  • Nonpsychoactive cannabinoids represent a potential advancement in neuropathic pain management.
  • Further research and clinical trials are warranted to optimize their use.
  • These agents may offer a safer alternative to existing neuropathic pain therapies.